Mercer Global Advisors Inc Athersys, Inc Transaction History

Mercer Global Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.18 - $0.86 $8,249 - $39,416	45,833 New	45,833 $12,000
Q1 2022 May 10, 2022	SELL	$0.6 - $1.06 $19,206 - $33,931	-32,011 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$0.85 - $1.4 $815 - $1,342	-959 Reduced 2.91%	32,011 $29,000
Q3 2021 Nov 10, 2021	SELL	$1.33 - $1.77 $10,545 - $14,034	-7,929 Reduced 19.39%	32,970 $44,000
Q2 2021 Aug 10, 2021	BUY	$1.41 - $1.94 $10,845 - $14,922	7,692 Added 23.16%	40,899 $59,000
Q1 2021 May 11, 2021	BUY	$1.61 - $2.77 $1,543 - $2,656	959 Added 2.97%	33,207 $60,000
Q4 2020 Feb 12, 2021	SELL	$1.55 - $2.24 $1,537 - $2,222	-992 Reduced 2.98%	32,248 $56,000
Q3 2020 Dec 10, 2020	BUY	$1.91 - $3.08 $63,488 - $102,379	33,240 New	33,240 $65,000
Q2 2020 Aug 10, 2020	SELL	$1.97 - $3.98 $49,644 - $100,296	-25,200 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$1.39 - $1.71 $35,028 - $43,092	25,200 New	25,200 $36,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.